BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

877 related articles for article (PubMed ID: 16227978)

  • 21. The role of scaffold proteins in MEK/ERK signalling.
    Sacks DB
    Biochem Soc Trans; 2006 Nov; 34(Pt 5):833-6. PubMed ID: 17052209
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Growth factor-induced MAPK network topology shapes Erk response determining PC-12 cell fate.
    Santos SD; Verveer PJ; Bastiaens PI
    Nat Cell Biol; 2007 Mar; 9(3):324-30. PubMed ID: 17310240
    [TBL] [Abstract][Full Text] [Related]  

  • 23. PKC isoenzymes differentially modulate the effect of thrombin on MAPK-dependent RPE proliferation.
    Palma-Nicolas JP; López E; López-Colomé AM
    Biosci Rep; 2008 Dec; 28(6):307-17. PubMed ID: 18636965
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Drosophila protein kinase LK6 is regulated by ERK and phosphorylates the eukaryotic initiation factor eIF4E in vivo.
    Parra-Palau JL; Scheper GC; Harper DE; Proud CG
    Biochem J; 2005 Feb; 385(Pt 3):695-702. PubMed ID: 15487973
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Regulatory mechanisms and function of ERK MAP kinases.
    Torii S; Nakayama K; Yamamoto T; Nishida E
    J Biochem; 2004 Nov; 136(5):557-61. PubMed ID: 15632293
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibition of influenza virus-induced NF-kappaB and Raf/MEK/ERK activation can reduce both virus titers and cytokine expression simultaneously in vitro and in vivo.
    Pinto R; Herold S; Cakarova L; Hoegner K; Lohmeyer J; Planz O; Pleschka S
    Antiviral Res; 2011 Oct; 92(1):45-56. PubMed ID: 21641936
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The JIP family of MAPK scaffold proteins.
    Whitmarsh AJ
    Biochem Soc Trans; 2006 Nov; 34(Pt 5):828-32. PubMed ID: 17052208
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Effects of extracellular signal-regulated kinase/mitogen-activated protein kinase signaling pathway activation on proliferation and cell cycle associated genes in human colon cancer cells].
    Wang X; Lu R; Fang JY
    Zhonghua Yi Xue Za Zhi; 2007 Apr; 87(14):982-6. PubMed ID: 17650425
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Raf kinase inhibitor protein regulation of raf and MAPK signaling.
    Hagan S; Garcia R; Dhillon A; Kolch W
    Methods Enzymol; 2006; 407():248-59. PubMed ID: 16757329
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Investigating dynamics of inhibitory and feedback loops in ERK signalling using power-law models.
    Vera J; Rath O; Balsa-Canto E; Banga JR; Kolch W; Wolkenhauer O
    Mol Biosyst; 2010 Nov; 6(11):2174-91. PubMed ID: 20717620
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Signalling pathway involving GULP, MAPK and Rac1 for SR-BI-induced phagocytosis of apoptotic cells.
    Osada Y; Sunatani T; Kim IS; Nakanishi Y; Shiratsuchi A
    J Biochem; 2009 Mar; 145(3):387-94. PubMed ID: 19122200
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Protein kinase D2 potentiates MEK/ERK/RSK signaling, c-Fos accumulation and DNA synthesis induced by bombesin in Swiss 3T3 cells.
    Sinnett-Smith J; Zhukova E; Rey O; Rozengurt E
    J Cell Physiol; 2007 Jun; 211(3):781-90. PubMed ID: 17226786
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A-Raf and Raf-1 work together to influence transient ERK phosphorylation and Gl/S cell cycle progression.
    Mercer K; Giblett S; Oakden A; Brown J; Marais R; Pritchard C
    Oncogene; 2005 Aug; 24(33):5207-17. PubMed ID: 15856007
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Resistance to MEK inhibitors: should we co-target upstream?
    Poulikakos PI; Solit DB
    Sci Signal; 2011 Mar; 4(166):pe16. PubMed ID: 21447797
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sorafenib (BAY 43-9006, Nexavar), a dual-action inhibitor that targets RAF/MEK/ERK pathway in tumor cells and tyrosine kinases VEGFR/PDGFR in tumor vasculature.
    Adnane L; Trail PA; Taylor I; Wilhelm SM
    Methods Enzymol; 2006; 407():597-612. PubMed ID: 16757355
    [TBL] [Abstract][Full Text] [Related]  

  • 36. KSR is a scaffold required for activation of the ERK/MAPK module.
    Roy F; Laberge G; Douziech M; Ferland-McCollough D; Therrien M
    Genes Dev; 2002 Feb; 16(4):427-38. PubMed ID: 11850406
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The EGF receptor activates ERK but not JNK Ras-dependently in basal conditions but ERK and JNK activation pathways are predominantly Ras-independent during cardiomyocyte stretch.
    Duquesnes N; Vincent F; Morel E; Lezoualc'h F; Crozatier B
    Int J Biochem Cell Biol; 2009 May; 41(5):1173-81. PubMed ID: 19015044
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Delta9-tetrahydrocannabinol-induced apoptosis in Jurkat leukemia T cells is regulated by translocation of Bad to mitochondria.
    Jia W; Hegde VL; Singh NP; Sisco D; Grant S; Nagarkatti M; Nagarkatti PS
    Mol Cancer Res; 2006 Aug; 4(8):549-62. PubMed ID: 16908594
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ras-mediated intestinal epithelial cell transformation requires cyclooxygenase-2-induced prostaglandin E2 signaling.
    Repasky GA; Zhou Y; Morita S; Der CJ
    Mol Carcinog; 2007 Dec; 46(12):958-70. PubMed ID: 17477350
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differential sensitivity of chemoresistant neuroblastoma subtypes to MAPK-targeted treatment correlates with ERK, p53 expression, and signaling response to U0126.
    Eppstein AC; Sandoval JA; Klein PJ; Woodruff HA; Grosfeld JL; Hickey RJ; Malkas LH; Schmidt CM
    J Pediatr Surg; 2006 Jan; 41(1):252-9. PubMed ID: 16410143
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 44.